An official website of the United States government
NIH Guide: Weekly Index for February 24, 2023
Weekly NIH Guide Notices
February 24, 2023
Policy Notices
-
Updated Process for Requesting Drawdowns Outside of the Liquidation Period
(NOT-OD-23-086)National Institutes of Health
General Notices
-
Request for Information on the NIH Plan to Enhance Public Access to the Results of NIH-Supported Research
(NOT-OD-23-091)Office of the Director, NIH
Notice of Changes to Funding Opportunities
-
Notice of Early Expiration of Notice of Special Interest (NOSI): Advancing Research Needed to Develop a Coccidioidomycosis (Valley fever) Vaccine" NOT-AI-23-007
(NOT-AI-23-030)National Institute of Allergy and Infectious Diseases
-
Notice of NIGMS Withdrawal of Participation from PA-22-177 "PHS 2022-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)"
(NOT-GM-23-032)National Institute of General Medical Sciences
-
Notice of NIGMS Withdrawal of Participation from PA-22-179 "PHS 2022-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)"
(NOT-GM-23-033)National Institute of General Medical Sciences
-
Notice of Participation of the National Human Genome Research Institute (NHGRI) in PA-20-163: Competing Revisions to Existing NIH Grants and Cooperative Agreements (Clinical Trial Optional)
(NOT-HG-23-021)National Human Genome Research Institute
-
Notice of Participation of NIMH in PAR-20-315, "Limited Competition: Lasker Clinical Research Scholars Transition Award (R00 Clinical Trial Optional)"
(NOT-MH-23-220)National Institute of Mental Health
-
Notice of Clarification Regarding Eligibility Information for SBIR/STTR Commercialization Readiness Pilot Program (CRP)
(NOT-OD-23-087)Office of the Director, NIH
-
Notice of Change to Minimum Performance Standards for SBIR and STTR Applicants
(NOT-OD-23-092)National Institutes of Health
Notices of Intent to Publish
-
Notice of Intent to Publish a Funding Opportunity Announcement for Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R01 Clinical Trial Optional)
(NOT-NS-23-068)National Institute of Neurological Disorders and StrokeNational Institute on AgingNational Institute of Mental Health
-
Notice of Intent to Publish a Funding Opportunity Announcement for Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R21 Clinical Trial Optional)
(NOT-NS-23-069)National Institute of Neurological Disorders and StrokeNational Institute on AgingNational Institute of Mental Health
Requests for Proposal
-
Pre-Solicitation Notice: Rational Systemic Characterization and Selection of Adjuvants for HIV Vaccine Candidates (R-CASA), RFP: 75N93022R00017
(NOT-AI-23-034)National Institute of Allergy and Infectious Diseases
Notices of Special Interest
-
Notice of Special Interest (NOSI): Advancing Research Needed to Develop a Coccidioidomycosis (Valley fever) Vaccine
(NOT-AI-23-031)National Institute of Allergy and Infectious Diseases
-
Notice of Special Interest (NOSI): Administrative Supplement to Support Health Policy Research in Cancer Prevention and Control
(NOT-CA-23-044)National Cancer Institute
-
Notice of Special Interest (NOSI): Administrative supplements to conduct systematic evidence reviews on the clinical utility of cancer-site specific polygenic risk scores (PRS) for cancer risk assessment
(NOT-CA-23-046)National Cancer Institute
-
Notice of Special Interest (NOSI) in Applications to Support Training, Workforce Development, and Diversity Conferences (R13)
(NOT-GM-23-028)National Institute of General Medical Sciences
-
Notice of Special Interest (NOSI): Enhancing Research on Deciphering Mechanisms of COVID-19-Associated Coagulopathy
(NOT-HL-23-080)National Heart, Lung, and Blood Institute
-
Notice of Special Interest (NOSI): Research supplements to promote workforce diversity and enhance utility and use of Common Fund datasets
(NOT-RM-23-005)Office of Strategic Coordination (Common Fund)National Human Genome Research Institute
Funding Opportunities
-
Genomics Centers for Infectious Diseases (U19 Clinical Trial Not Allowed)
(RFA-AI-23-015)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): June 2, 2023
-
Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction with Substance Use Disorder (R01 Clinical Trials Not Allowed)
(RFA-DA-24-008)National Institute on Drug AbuseNational Library of MedicineApplication Receipt Date(s): August 10, 2023
-
Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction with Substance Use Disorder (R21 Clinical Trials Not Allowed)
(RFA-DA-24-009)National Institute on Drug AbuseNational Library of MedicineApplication Receipt Date(s): August 10, 2023
-
Natural History and Biomarker Studies of Rare Neurodegenerative Diseases (U01) Clinical Trials Optional
(RFA-FD-23-028)Food and Drug AdministrationApplication Receipt Date(s): May 4, 2023
-
NIOSH Robotics and Intelligent Mining Technology and Workplace Safety Research (U60)
(RFA-OH-23-005)National Institute for Occupational Safety and HealthApplication Receipt Date(s): September 29, 2024
NIH Guide Notices are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
For technical issues E-mail OER Webmaster